Cytori Cell Research Institute, Inc. (3750.T)
JPY 671.0
(-0.74%)
JPY 671.0
(-0.74%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.34 Billion JPY | -69.14% |
| 2022 | 7.6 Billion JPY | -11.05% |
| 2021 | 8.55 Billion JPY | 6.71% |
| 2020 | 8.01 Billion JPY | -2.49% |
| 2019 | 8.21 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 2.33 Billion JPY | -0.56% |
| 2023 Q3 | 6.84 Billion JPY | -7.54% |
| 2023 FY | 2.34 Billion JPY | -69.14% |
| 2023 Q4 | 2.34 Billion JPY | -65.7% |
| 2023 Q2 | 7.4 Billion JPY | -1.39% |
| 2023 Q1 | 7.5 Billion JPY | -1.31% |
| 2022 Q3 | 7.74 Billion JPY | -0.64% |
| 2022 Q2 | 7.78 Billion JPY | 0.0% |
| 2022 Q4 | 7.6 Billion JPY | -1.73% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | -205.994% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | -17.354% |
| Linical Co., Ltd. | 1.49 Billion JPY | -56.477% |
| Trans Genic Inc. | 1.32 Billion JPY | -76.861% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -300422.279% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| AnGes, Inc. | 214.94 Million JPY | -991.924% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -2096.632% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 96.287% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -2675.605% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -111.655% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -8163.781% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | -168.054% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -5910.446% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | -27.7% |
| PeptiDream Inc. | 19.63 Billion JPY | 88.046% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -1356.908% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -491.204% |
| Healios K.K. | 450 Million JPY | -421.573% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -2936.678% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | -203.518% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | -197.853% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | -377.679% |
| StemCell Institute Inc. | 6.67 Million JPY | -35056.965% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -1532.751% |